-
Natrecor: An Example Of How Drug Companies Might Influence Doctors
"Off-label" Prescribing Is At Center Of Ongoing Natrecor Controversy A recent article of interest is "The Rise And Fall Of Natrecor For Congestive Heart Failure: Implications For Drug Policy", by Aaron S. Kesselheim, Michael…
-
Ketek Allegedly “More Toxic Than Most Other Drugs”
Dr. David Graham At FDA Wants An "Immediate Withdrawal" Of Ketek On the morning of July 19, 2006 a National Public Radio (NPR) news piece about Ketek brought our attention back to this increasingly…
-
Recent Developments In The Federal Court Vioxx MDL Litigation
<p><strong><span style="font-size: 1.2em;">UPDATE: Global Settlement Offer Made By Merck To End Vioxx Litigation According To November 9, 2007 News Reports</span></strong></p> <p><strong><span style="font-size: 1.2em;"><p><a href="http://www.nytimes.com/2007/11/09/business/09merck.html?_r=1&th&emc=th&oref=slogin">Merck Agrees to Settle Vioxx Suits for $4.85 Billion </a>(NY Times)</p>…
-
Drug Errors Occur At All Points In Medication Process
Implementation Of Monitoring Programs Can Reduce And Prevent Mistakes In June 2006 the medical journal Quality & Safety in Healthcare published an article, "Computer based medication error reporting: insights and implications", that demonstrated drug…
-
Association of Sudden Vision Loss / NAION With Erectile Dysfunction (ED) Drugs
A "Dear Doctor" Letter Was Sent In June 2006, But Only In Canada As reported previously, the erectile dysfunction (ED) drugs Cialis (tadalafil), Levitra (vardenafil hydrochloride), and Viagra (sildenafil citrate) have been associated with…
